MENU

Astellas Oncology C3 Prize

C3

We fuel the best ideas in cancer care beyond medicine, sparking innovation to improve care for people with cancer, their caregivers, and the broader oncology community.

About the C3 Prize

Cancer is complex. Astellas Oncology recognizes the complexities of the cancer journey – in addition to medicine, people with cancer need comprehensive care.

That’s why we committed to fueling big ideas that tackle everyday challenges in cancer care beyond medicine. The C3 (Changing Cancer Care) Prize sparks the growth of developments to improve cancer care for people with cancer, caregivers and their loved ones by awarding $200,000 in grants and resources to advance ideas that make a big impact in the cancer community. The C3 Prize directly reflects the mission of Astellas Oncology: to make every day better for those impacted by cancer.

Questions about Astellas Oncology? Download our 1-Pager


C3 Prize in the News

The Doctors

“Cancer touches so many people, so many lives, in so many ways and I wanted to make a difference… After Giuliana got through her breast cancer, we both said we were going to try to make this journey easier for the people behind us.”

Bill Rancic, Cancer Activist and Entrepreneur

FiercePharma

“The reason we do this program is we want to provide impact beyond medicine for patients living with cancer. Our medicines are only part of the solution, probably a relatively small part of the solution actually. By doing this innovation contest hopefully, we can bring forward and nurture some ideas that will help patients and their caregivers.”

Mark Reisenauer, Senior Vice President, Astellas Oncology Business Unit

Thrive Global

“The Astellas Oncology C3 Prize impacted b-present in several important ways including putting us on the map, giving us resources to improve our technology, increasing our reach, and improving our storytelling.”

Abby Westerman, Founder, b-present Foundation, 2019 C3 Prize Emerging Ideas Prize Winner


An Award-Winning Program

Sign up to receive occasional updates on C3 Prize news.

Join us virtually as the three finalists pitch their ideas in March 2021. We will also keep you posted on winner updates and how you can get involved in next year's C3 Prize.

*Required field

By submitting your information, you acknowledge that you have read and agreed to the Astellas Online Privacy Statement. You also agree to receive emails from Astellas and understand that you may opt out of Astellas subscriptions at any time.

Winning Ideas

Nurturing grassroots ideas has resulted in incredible impact over the years. Our innovators have been able to help those with cancer—and their loved ones—in ways we never would have imagined on our own. Want to learn about this year's finalists?

2019 Grand Prize Winner

Audrey Guth

Audrey Guth
Nanny Angel Network

Idea: Expand the reach and impact of Nanny Angel Network, which delivers free, specialized childcare for mothers with cancer.

Planned Impact:

  • Increase the number of mothers supported
  • Develop a Family Advisory Committee to solicit feedback on the program
  • Increase outreach with oncology and social work departments at hospitals
  • Develop grief and bereavement coping kit for children
  • Purchase a medical teaching doll to help explain medical interventions to children
  • Establish a program to subsidize summer camp expenses for children
  • Recruit and provide additional training for volunteers

2018 Grand Prize Winner

Ebele Mbanugo

Ebele Mbanugo
Run For a Cure Africa (RFCA)

Idea: Produce timely, culturally relevant, relatable information via a first-of-its-kind digital audio series with local actors that addresses common barriers and myths to breast cancer treatment, which are of value to patients in Nigeria.

2017 Grand Prize Winner

Hernâni Oliveira

Hernâni Oliveira
The Hope Project

Idea: An augmented reality app to help solve common issues faced by pediatric patients and their parents around both education and physical engagement.

“With the Astellas Oncology C3 Prize we will be able to perform more users’ tests in order to prove the association between the use of this video game and hospitalization time. The award will also allow us to launch the parents and caregivers app in three different languages: English, French and Portuguese.”

2016 Grand Prize Winner

Hernâni Oliveira

Diane Jooris
Oncomfort™

Idea: Virtual reality systems to help patients by providing anxiety and pain self-management tools.

“The C3 Prize provided my company with the resources needed to complete development of a new virtual reality module, as well as invaluable exposure for our idea. Being part of the C3 Prize has been such a rewarding experience that we named the new module ‘Stella’ in honor of the company that made it possible.”

C3 Prize Alumni

Meet the Judges of the 5th Annual C3 Prize

Steve Alperin

Steve Alperin
CEO, SurvivorNet

Steve Alperin is the CEO of SurvivorNet, a consumer-focused media platform that has brought experts from the top comprehensive cancer centers together in one place online. He co-founded SurvivorNet to help people struggling to connect with the right doctors and the right information when faced with a cancer diagnosis. The idea for SurvivorNet was spurred from his father's cancer diagnosis and the absence of clear information about it. The company aims to empower those looking for answers by bringing the best medical advice from premier doctors around the world directly to users.

Steve has spent twenty years managing large national news outlets in the U.S and creating innovative digital platforms. He previously served as the Head Writer and Producer for ABC's World News Tonight with Peter Jennings and the Managing Editor of ABCNews.com. Steve has created thousands of hours of programming for television and digital and worked to develop content for major brands across healthcare and media; including Yale, MSNBC, Showtime, Tesaro/GSK, and Novartis. He has been recognized for excellence in journalism with The Writers Guild of America, Dupont, and Edwards R. Murrow awards. Steve received a Bachelor’s in government from Harvard and an MBA from Columbia Business School.

Steve Collens

Steven Collens
CEO, MATTER

Steven Collens is CEO of MATTER, the healthcare technology incubator and innovation center. MATTER opened in February 2015 and nurtures entrepreneurs and innovators building next-generation health IT, medical device, diagnostic and biopharma technologies. MATTER works with more than 200 healthcare technology ventures and the company partners with dozens of industry-leading companies, health systems and universities. Steven is also senior advisor at Pritzker Group Venture Capital.

Prior to assuming his current role, Steven was senior vice president at Pritzker Group, the investment firm led by Tony and J.B. Pritzker. In that capacity, he led the team that created 1871, Chicago’s center for digital startups that now houses more than 400 early-stage companies. He previously worked at Abbott in a variety of domestic and international functions, including product management, policy and public affairs. In 2005, Steven helped found ConstantWellness.com to give patients control over their health data and allow healthcare providers to coordinate care of their patients. Prior to Abbott, Steven served as legislative assistant to U.S. Senator Carol Moseley-Braun.

Steven holds an MBA from Northwestern University’s Kellogg School of Management and a BA from Washington University in St. Louis. He serves on the boards of 1871, Hubbard Street Dance Chicago and the Chicago High School for the Arts, and is a member of ChicagoNEXT, Mayor Lori Lightfoot’s council on technology and innovation. He is also a Leadership Greater Chicago fellow and a member of the Economic Club of Chicago and the Commercial Club of Chicago.

Margaret Laws

Margaret Laws
CEO, Hopelab

Margaret Laws is a catalytic leader in health care, forging cross-sector partnerships that drive positive social impact. She is the President and CEO of HopeLab, where she leads a team to create science-based technologies to improve the health and well-being of teens and young adults. Margaret also founded the CHCF Health Innovation Fund, a mission-focused investment fund supporting companies that improve access to and lower costs of health care.

Margaret is passionate about bringing together government, nonprofit and private-sector stakeholders interested in advancing the role technology can play in supporting and improving health outcomes, with a particular focus on underserved populations.

Ebele Mbanugo

Ebele Mbanugo, Ed.D
2018 C3 Grand Prize winner, Executive Director at Run For a Cure Africa Breast Cancer Foundation

Dr. Ebele Mbanugo is the founder and Chief Executive Officer of Run For a Cure Africa Breast Cancer Foundation (RFCA). After her mother’s battle with breast cancer, she founded RFCA in 2009 with the vision of providing free breast cancer screenings to the underserved women of Nigeria. This program has now grown into an organization with a presence across West Africa. RFCA has provided over 14,000 free breast cancer screenings to women and men throughout Ghana, Nigeria, and Cameroon and RFCA also works with federal hospitals and local ministries of health to provide greater access to quality breast cancer care. RFCA, through Dr. Ebele Mbanugo’s leadership, established one of Nigeria’s first patient navigation programs (PNP) in 2016. This program has supported over 2,000 patients on their breast health journey. In 2016, RFCA commissioned the first and exclusive breast cancer care clinic in Nigeria at the largest public hospital in Nigeria, The Lagos University Teaching Hospital (LUTH).

She is an active member of UICC, Advanced Breast Cancer Global Alliance, and the American Society of Clinical Oncologist (ASCO). Ebele has a Master’s in Educational Administration and a Doctorate in Education.

Mark Reisanaver

Mark Reisenauer
Senior Vice President, Astellas Oncology Business Unit

Mark Reisenauer has been Senior Vice President of the Oncology Business Unit at Astellas Pharma US, Inc., since May 2011. A veteran oncology commercial leader, Mark is responsible for all US commercial activities supporting marketed products and commercial planning for late-stage development compounds.

Mark earned a bachelor’s degree in political science from the University of Wisconsin.

Join us to find out who will win the Grand Prize!

Mark your calendar for March 23, 2021, when you can join a virtual watch party hosted by celebrity entrepreneur and cancer activist Bill Rancic and watch the finalists pitch their ideas to an expert judging panel of leaders in business, innovation and cancer care.

During the finalist pitch event, one Grand Prize winner will receive $100,000 and two Innovation Prize winners will receive $50,000 in grants and resources. All winners will be provided with access to tools and resources to help them develop and advance their idea, including a yearlong complimentary membership to MATTER, a global healthcare startup incubator, community nexus and corporate innovation accelerator. The Grand Prize winner will also receive hands-on support, expertise, and resources from Slalom, a modern consulting firm focused on strategy, technology, and business transformation.

To find out more about the event, sign up for C3 Prize updates.

All eligible entries will be evaluated on these criteria: potential impact on people affected by cancer, originality/differentiation from existing solutions, scalability of idea, and the impact of the C3 Prize on the ability to further the idea, based on the C3 Prize Terms & Conditions.

Stay Connected

Let’s stay in touch. Follow us on social media or sign up for the latest updates.

*Required field.

By submitting your information, you acknowledge that you have read and agreed to the Astellas Online Privacy Statement. You also agree to receive emails from Astellas and understand that you may opt out of Astellas subscriptions at any time.

*Required field.

By submitting your information, you acknowledge that you have read and agreed to the Astellas Online Privacy Statement . You also agree to receive emails from Astellas and understand that you may opt out of Astellas subscriptions at any time.

Thank You! We'll be in touch.